ライフサイエンスコーパス: anti-inflammation

1 e production in RAW264.7 cells (a measure of anti-inflammation).

2 possible regulatory pathways of MC1-R beyond anti-inflammation.

3 applied to antimutation, antityrosinase and anti-inflammation.

4 compounds i.e. anti-cancer, anti-allergy and anti-inflammation.

5 for its pharmacological functions including anti-inflammation.

6 anced cellular DNA repair, antioxidation and anti-inflammation.

7 f miR-33 that mediates simvastatin-triggered anti-inflammation.

8 nnexin A1 (AnxA1), an effector of endogenous anti-inflammation.

9 ects in vasodilation, anti-angiogenesis, and anti-inflammation.

10 Progesterone treatment showed no significant anti-inflammation action on cytokine concentrations.

11 ced neurodegeneration involving antioxidant, anti-inflammation and anti-apoptotic mechanisms.

12 The anti-inflammation and anti-infection functions for Vitam

13 The involvement of Vitamin D/VDR in anti-inflammation and anti-infection represents a newly

14 ovel cyclooxygenase inhibitors, may serve as anti-inflammation and anticancer agents, and may contrib

15 Berberine has several anti-inflammation and anticancer biologic effects.

16 nt of green tea extract, exhibits effects of anti-inflammation and antioxidation on periodontal infla

17 sts that WLT can be applied to antimutation, anti-inflammation and antityrosinase.

18 atins have shown pleiotropic effects such as anti-inflammation and bone stimulation.

19 ontributing to the development of a state of anti-inflammation and dichotomy of immunologic polarizat

20 n important role in endogenous mechanisms of anti-inflammation and pro-resolution.

21 sal antimicrobial responses demonstrate that anti-inflammation and proresolution are different respon

22 There is an important distinction between anti-inflammation and resolution; anti-inflammation is p

23 d protective processes: Th2 cytokine-induced anti-inflammation and ROS reduction.

24 ced KLF2 and eNOS expression as well as flow anti-inflammation, and suggest that HDAC5 could be a pot

25 signaling, cell migration, tissue survival, anti-inflammation, and T-cell-mediated cellular immunity

26 tiatherogenic effects of HDL (antioxidation, anti-inflammation, antithrombotic effects, endothelial s

27 acid-stimulated neutrophils, consistent with anti-inflammation but not COX inhibition (IC50s = 1-8 mM

28 pha transcription and suggest a mechanism of anti-inflammation by the antioxidants through control of

29 efficacy in lung function, QOL, and possibly anti-inflammation compared with BUD plus Tulo treatment.

30 ic functions for this effector of endogenous anti-inflammation could be unveiled by studying collagen

31 haracterize the balance of systemic pro- and anti-inflammation early after burn and inhalation injury

32 2-nHP66 scaffold exerts potent antibacterial/anti-inflammation effects in vivo and promotes bone form

33 )-induced metabolic diseases due to enhanced anti-inflammation engineered by lowering receptor intera

34 ranscriptional regulator for antioxidant and anti-inflammation enzymes that binds to its endogenous i

35 ta has been shown to play a critical role in anti-inflammation; however, the signaling mechanisms of

36 Anti-inflammation immunotherapy has been successfully ap

37 10 was a critical mediator for PGRN-mediated anti-inflammation in collagen-induced arthritis by using

38 s model to explore the importance of dynamic anti-inflammation in promoting resolution of infection a

39 on between anti-inflammation and resolution; anti-inflammation is pharmacologic intervention in infla

40 o be a key pathway by which immunomodulation/anti-inflammation may operate.

41 tosterol showed a strong Th2-inclination and anti-inflammation potential in vitro.

42 sting that these terpenoid compounds have an anti-inflammation potential through the inhibition of T-

43 in the 1980s demonstrated that pharmacologic anti-inflammation prevented and slowed the progression o

44 3 eicosapentaenoic acid that displays potent anti-inflammation/pro-resolution actions in vivo.

45 ein A-I mimetic peptide with antioxidant and anti-inflammation properties on a high-fat or normal cho

46 -beta1 is a pleiotropic cytokine with potent anti-inflammation property.

47 n (EPRAP), whose function in PGE(2)-mediated anti-inflammation remains undefined.

48 tion and bone loss, suggesting that enhanced anti-inflammation status is an active process.

49 ng in extra-hepatic tissues by statins as an anti-inflammation strategy.

50 ng Gbetagamma-regulation may be an effective anti-inflammation strategy.

51 To investigate the molecular mechanism of anti-inflammation, we analyzed the regulation of tumor n